Medical News

RSS

Telephone interventions for physical activity and dietary behavior change

"Phoning it in" works when it comes to losing weight and getting fit, according to a new systematic review.

11 Apr 2007

Pharmatek Laboratories opens new facility in San Diego

Pharmatek Laboratories has announced the opening of its new 34,000 sq. ft. facility at 7330 Carroll Road, San Diego, California 92121.

11 Apr 2007

Pharmacopeia announces positive results in hypertension and diabetic nephropathy trial

Pharmacopeia ( NASDAQ:PCOP ) , an innovator in the discovery and development of novel small molecule therapeutics, today announced positive results from the initial Phase 1 clinical trial of PS433540, the company's lead internal product candidate for the treatment of hypertension and diabetic nephropathy.

11 Apr 2007

Renovis and Pfizer extend research collaboration

Renovis has announced an agreement with Pfizer to extend the term of the companies' worldwide collaboration to research, develop and commercialize small molecules that target the vanilloid receptor, VR1.

11 Apr 2007

Parata Systems acquires prescription pickup technology

Parata Systems, LLC today announced it acquired the assets of Amistar (BULLETIN BOARD: AMTA.PK) and Distributed Delivery Networks Corporation related to automated product machine (APM) technology, which enables prescription pickup via self-service kiosks.

11 Apr 2007

Rising vaccine costs put kids at risk

The American Academy of Pediatrics (AAP) is alarmed that the soaring costs of vaccines combined with lower reimbursements from insurance companies will lead to the under- immunization of the nation's children and unnecessary outbreaks of preventable diseases.

11 Apr 2007

Suicide rates in Oregon higher than California

Two co-sponsors of a bill to legalize assisted suicide in California participated in a press conference promoting a bill to create an Office of Suicide Prevention in California.

11 Apr 2007

Full impact of mental health and substance abuse disorders on U.S. community hospitals

Almost one-fourth of all stays in U.S. community hospitals for patients age 18 and older – 7.6 million of nearly 32 million stays – involved depressive, bipolar, schizophrenia and other mental health disorders or substance use related disorders in 2004, according to a new report by HHS' Agency for Healthcare Research and Quality.

11 Apr 2007

OHSU surgeon implants donated tissue allografts

Over the years, orthopedic surgeon Dennis Crawford, M.D., Ph.D., of Oregon Health & Science University found it difficult to obtain tissue for transplant to treat some of his patients suffering with severe joint disorders.

11 Apr 2007

Rep. Dave Weldon comments on stem therapy and type I diabetes

In yet another advance in adult stem cell therapy, the Journal of the American Medical Association (JAMA) today released a study in which 14 of 15 Juvenile Diabetes patients demonstrated significant improvement as a result of an adult stem cell treatment.

11 Apr 2007

Novalar Pharmaceuticals submits NDA for dental anesthetic reversal agent

Novalar Pharmaceuticals, Inc. today announced the submission of a New Drug Application (NDA) to the U. S. Food and Drug Administration (FDA) for marketing approval of NV-101, a local dental anesthetic reversal agent.

11 Apr 2007

Gene finding could lead to new pathways for development of Alzheimer's therapeutics

Scientists have known for more than a decade that individuals with a certain gene are at higher risk for developing Alzheimer's disease.

11 Apr 2007

Fostering the advancement of women and minority physicians in academic medicine

Although men and women attend medical school in equal numbers, for most women who go on to academic medicine, that's where the numbers stop adding up.

11 Apr 2007

Most promising drugs in development for metabolic syndrome

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that emerging agents from Metabolex/Johnson & Johnson, Merck, Novartis, and Amylin/Eli Lilly are among the most promising drugs in development for metabolic syndrome.

11 Apr 2007